Do hIV reverse-transcriptase drug resistance mutations during early infection reveal greater transmission diversity than in envelope sequences?
Reverse-transcriptase DRMs demonstrate that the breadth of variants in transmission may be greater than what is reflected in envelope sequences.
HMB may be a useful agent to consider for modulation of immune function in specific situations.